Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ales Mrhar

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
International Journal of Pharmaceutics|August 15, 2009
Challenges in Nano- Micro- and Macro-systems. PrefaceAles Mrhar, Sasa Baumgartner
Journal of Pharmaceutical and Biomedical Analysis|July 11, 2009
Simultaneous determination of risperidone and 9-hydroxyrisperidone enantiomers in human blood plasma by liquid chromatography with electrochemical detectionIgor Locatelli, Ales Mrhar, Iztok Grabnar
European Journal of Public Health|July 14, 2010
Cost-effectiveness analysis of HPV vaccination alongside cervical cancer screening programme in SloveniaMarko Obradovic, Ales Mrhar, Mitja Kos
European Journal of Clinical Pharmacology|March 17, 2017
Comparative analysis of three drug-drug interaction screening systems against probable clinically relevant drug-drug interactions: a prospective cohort studyNeža Muhič, Ales Mrhar, Miran Brvar
Pharmacy World & Science : PWS|February 3, 2005
Evaluation of the introduction of an antimicrobial drugs formulary in a general hospital in SloveniaJure Peklar, Franci Tratar, Ales Mrhar
Pharmacogenomics|May 10, 2008
Cost-effectiveness of UGT1A1 genotyping in second-line, high-dose, once every 3 weeks irinotecan monotherapy treatment of colorectal cancerMarko Obradovic, Ales Mrhar, Mitja Kos
Pharmaceutical Research|April 2, 2009
Gastric emptying of pellets under fasting conditions: a mathematical modelIgor Locatelli, Ales Mrhar, Marija Bogataj
Clinical Therapeutics|January 30, 2010
Market uptake of biologic and small-molecule--targeted oncology drugs in EuropeMarko Obradovic, Ales Mrhar, Mitja Kos
Biological & Pharmaceutical Bulletin|May 8, 2009
Antioxidant levels in the pig urinary bladder: distribution within the bladder wall and in the urothelium derived from different bladder regionsTomaz Vovk, Marija Bogataj, Ales Mrhar
European Journal of Cancer (Oxford, England : 1990)|December 25, 2007
Accessibility to targeted oncology drugs in Slovenia and selected European countriesMitja Kos, Marko Obradovic, Ales Mrhar
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
International Journal of Pharmaceutics|August 15, 2009
Challenges in Nano- Micro- and Macro-systems. PrefaceAles Mrhar, Sasa Baumgartner
Journal of Pharmaceutical and Biomedical Analysis|July 11, 2009
Simultaneous determination of risperidone and 9-hydroxyrisperidone enantiomers in human blood plasma by liquid chromatography with electrochemical detectionIgor Locatelli, Ales Mrhar, Iztok Grabnar
European Journal of Public Health|July 14, 2010
Cost-effectiveness analysis of HPV vaccination alongside cervical cancer screening programme in SloveniaMarko Obradovic, Ales Mrhar, Mitja Kos
European Journal of Clinical Pharmacology|March 17, 2017
Comparative analysis of three drug-drug interaction screening systems against probable clinically relevant drug-drug interactions: a prospective cohort studyNeža Muhič, Ales Mrhar, Miran Brvar
Pharmacy World & Science : PWS|February 3, 2005
Evaluation of the introduction of an antimicrobial drugs formulary in a general hospital in SloveniaJure Peklar, Franci Tratar, Ales Mrhar
Pharmacogenomics|May 10, 2008
Cost-effectiveness of UGT1A1 genotyping in second-line, high-dose, once every 3 weeks irinotecan monotherapy treatment of colorectal cancerMarko Obradovic, Ales Mrhar, Mitja Kos
Pharmaceutical Research|April 2, 2009
Gastric emptying of pellets under fasting conditions: a mathematical modelIgor Locatelli, Ales Mrhar, Marija Bogataj
Clinical Therapeutics|January 30, 2010
Market uptake of biologic and small-molecule--targeted oncology drugs in EuropeMarko Obradovic, Ales Mrhar, Mitja Kos
Biological & Pharmaceutical Bulletin|May 8, 2009
Antioxidant levels in the pig urinary bladder: distribution within the bladder wall and in the urothelium derived from different bladder regionsTomaz Vovk, Marija Bogataj, Ales Mrhar
European Journal of Cancer (Oxford, England : 1990)|December 25, 2007
Accessibility to targeted oncology drugs in Slovenia and selected European countriesMitja Kos, Marko Obradovic, Ales Mrhar
Pageof 5